Browsing by Author "Putrins, Davis Simanis"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Can intratumoural vascularisation CT contrast dynamics help differentiate malignant renal tumour subtypes?
    (2023) Putrins, Davis Simanis; Radzina, Maija; Liepa, Māra; Maļika- Popova, Ņina; Saule, Laura; Ratniece, Madara; Vjaters, Egils; Jukonis, Jānis; Briede, Inese; Department of Radiology; Onkoloģijas institūts; Department of Pathology
  • No Thumbnail Available
    Item
    Performance of contrast-enhanced ultrasound in thyroid nodules : Review of current state and future perspectives
    (2021-10-30) Radzina, Maija; Ratniece, Madara; Putrins, Davis Simanis; Saule, Laura; Cantisani, Vito; Department of Radiology
    Ultrasound has been established as a baseline imaging technique for thyroid nodules. The main advantage of adding CEUS is the ability to assess the sequence and intensity of vascular perfusion and hemodynamics in the thyroid nodule, thus providing real-time characterization of nodule features, considered a valuable new approach in the determination of benign vs. malignant nod-ules. Original studies, reviews and six meta-analyses were included in this article. A total of 624 studies were retrieved, and 107 were included in the study. As recognized for thyroid nodule malignancy risk stratification by US, for acceptable accuracy in malignancy a combination of several CEUS parameters should be applied: hypo-enhancement, heterogeneous, peripheral irregular enhancement in combination with internal enhancement patterns, and slow wash-in and wash-out curve lower than in normal thyroid tissue. In contrast, homogeneous, intense enhancement with smooth rim enhancement and “fast-in and slow-out” are indicative of the benignity of the thyroid nodule. Even though overlapping features require standardization, with further research, CEUS may achieve reliable performance in detecting or excluding thyroid cancer. It can also play an op-erative role in guiding ablation procedures of benign and malignant thyroid nodules and metastatic lymph nodes, and providing accurate follow-up imaging to assess treatment efficacy.